You are required to be logged in to access the full website
Click here if you have forgotten your username or password
10 July 2025 - US biogenetics company Klotho Neurosciences, Inc. (NASDAQ:KLTO) announced on Thursday that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to KLTO-202, its lead gene therapy candidate for the treatment of ...
10 July 2025 - Oncology company BeOne Medicines Ltd (NASDAQ:ONC) (HKEX:06160) (SSE:688235) announced on Thursday that the European Commission has approved TEVIMBRA (tislelizumab) in combination with gemcitabine and cisplatin as a first-line treatment...
10 July 2025 - Needle-free injection technology company PharmaJet said on Thursday that it has signed a Memorandum of Understanding with the Egyptian Unified Procurement Authority (UPA) and EVA Pharma to explore the integration of needle-free deliver...
10 July 2025 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) and Japanese pharmaceutical company Astellas Pharma Inc (TSE:4503) on Thursday announced positive overall survival results from the Phase 3 EMBARK study evaluating XTANDI (enzalutamide...
10 July 2025 - MetaVia Inc (Nasdaq:MTVA), a US-based clinical-stage biotechnology company focused on cardiometabolic diseases, announced on Wednesday that the first patient has been dosed in the 48 mg, multiple ascending dose (MAD) cohort of its Phas...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe